Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?

Key Findings:  The currently available preclinical and clinical evidence points to CBD as a promising treatment strategy for these patient populations.

Type of Study:  Meta-analysis

Study Result:  Positive

Study Location(s):  Brazil

Year of Pub:  2019

Cannabinoids Studied:  Cannabidiol (CBD)

Phytocannabinoid Source:  Unspecified

Chemotype:  Chemotype III